Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for Radiation Toxicity in Breast Cancer
NCT02012608Phase 2Terminated
- Sponsor
- University of Arkansas
- Start
- Jun 2014
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in acute radiation syndrome (ARS), sponsored by University of Arkansas. Started Jun 2014; status: terminated.
02
Drugs
glutamine
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT02012608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012608.